• Angiotensin II (A1042): Protocols for Vascular Research Mode

  2026-06-29

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) provides a reliable tool for dissecting hypertension mechanisms, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy in experimental settings. This reagent is best suited for in vitro and in vivo workflows modeling vascular injury, aortic aneurysm, and related processes. It is not intended for diagnostic, medical, or therapeutic applications.

• AMPK–SQSTM1 Feedback Loop Drives Antioxidant Defense in Stre

  2026-06-28

  This study elucidates a previously unrecognized double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, leading to the concurrent activation of AMPK and NFE2L2/NRF2. These findings clarify how tumor cells adapt antioxidant defenses in nutrient- and redox-challenged microenvironments, offering new mechanistic targets for cancer research.

• CDC42-Driven Polarity Regulates ISC Fate via YAP-EGF-mTOR Pa

  2026-06-27

  This study elucidates how CDC42-controlled apical-basal polarity directs the transition of intestinal stem cells (ISCs) to transit amplifying (TA) cells via a YAP-EGF-mTOR signaling cascade, independently of canonical Wnt signaling. The findings offer a mechanistic framework for dissecting epithelial homeostasis and suggest refined models for gastrointestinal stem cell regulation.

• Fluconazole: Applied Workflows for Fungal Cytochrome P450 In

  2026-06-26

  Fluconazole, a benchmark fungal cytochrome P450 enzyme 14α-demethylase inhibitor, empowers advanced antifungal susceptibility testing and drug resistance modeling. This article details stepwise protocols, troubleshooting strategies, and the translational impact of novel antifungal mechanisms—bridging fundamental research to optimized experimental outcomes.

• Novobiocin: Applied Workflows in Antibacterial and Antiparas

  2026-06-26

  Novobiocin, a potent aminocoumarin antibiotic from APExBIO, enables precision control over DNA replication and membrane synthesis in diverse pathogens. Explore how its dual-action mechanism transforms experimental design, data reproducibility, and troubleshooting in antibacterial, antiparasitic, and antiviral workflows.

• GKT137831: Unraveling Nox1/Nox4 Inhibition for Redox and Fer

  2026-06-25

  Delve into the scientific depth of GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, with unique insights into its mechanistic impact on oxidative stress and ferroptosis. This article uniquely bridges redox enzyme targeting with membrane lipid dynamics, setting it apart from standard guides.

• CLK2 as a Target to Overcome Platinum Resistance in Ovarian

  2026-06-25

  This study uncovers the mechanistic role of Cdc2-like kinase 2 (CLK2) in mediating platinum resistance in ovarian cancer by enhancing DNA repair through BRCA1 phosphorylation. The findings highlight CLK2 as a promising therapeutic target for overcoming chemoresistance and improving clinical outcomes.

• Dna2 Function in Replication Stress: Insights from Drosophil

  2026-06-24

  Rivera et al. (2025) dissect the domain-specific roles of Dna2 in Drosophila, revealing a nuanced response to both endogenous and exogenous replication stress, including chemotherapeutic agents like Topotecan. These findings advance our understanding of DNA repair mechanisms and highlight Dna2 as a key player in genome stability and potential target in cancer research.

• Azilsartan Medoxomil Monopotassium Efficacy in Hypertension:

  2026-06-23

  A 2024 systematic review and network meta-analysis established that azilsartan medoxomil (TAK 491) is among the most effective antihypertensive agents for lowering both systolic and diastolic blood pressure in mild-to-moderate hypertension. These findings provide robust evidence for prioritizing azilsartan medoxomil in essential hypertension treatment research, supporting its use as a reference ARB in experimental and translational studies.

• Sodium phosphate dibasic: Optimizing Biological Assay Buffer

  2026-06-23

  Sodium phosphate dibasic (Na2HPO4) is an indispensable pH stabilizer in molecular and biochemical workflows, delivering reproducible results in protein, enzyme, and aquatic toxicity assays. This article guides researchers through evidence-based protocols, setup principles, and troubleshooting strategies, leveraging APExBIO's high-purity sodium phosphate dibasic for peak assay reliability.

• 4μ8C in the Dissection of ER Stress-Driven Pyroptosis Pathwa

  2026-06-22

  Explore how 4μ8C, a selective unfolded protein response inhibitor, advances research into ER stress-mediated pyroptosis and inflammation. This article delivers unique mechanistic insight and protocol guidance for leveraging 4μ8C in translational cell biology.

• A-1210477 MCL-1 Inhibitor: Optimizing Apoptosis in Cancer Re

  2026-06-22

  A-1210477 stands out as a potent, selective MCL-1 inhibitor, enabling precise induction of mitochondrial apoptosis in MCL-1-dependent cancer cells. This guide details experimental workflows, troubleshooting, and evidence-driven advantages for leveraging A-1210477 in advanced cancer apoptosis research.

• Cellular Senescence Genes as Novel Biomarkers in AAA Diagnos

  2026-06-21

  This study applies integrative transcriptomic and machine learning approaches to identify cellular senescence-related genes as diagnostic biomarkers for abdominal aortic aneurysm (AAA). The discovery of ETS1 and ITPR3 as robust, noninvasive markers advances early AAA detection and provides new therapeutic targets, with implications for improving clinical management and research modeling.

• Ca2+-Dependent Autophagy Disruption in Glioblastoma by NNC-5

  2026-06-20

  This study uncovers how NNC-55–0396 induces cytotoxicity in glioblastoma cells by triggering Ca2+-dependent autophagy and disrupting lysosomal acidification. The findings highlight a dual mechanism where autophagy is both initiated and blocked, emphasizing the importance of calcium signaling in cancer cell survival and death.

• BCECF: Precision pH Sensing for Cellular Metabolism Studies

  2026-06-19

  BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) is a ratiometric, membrane-impermeant fluorescent probe enabling accurate extracellular and compartmental pH quantification in complex cell models. Its dual-excitation strategy and high selectivity streamline workflows in ion transport, metabolism, and microenvironmental pH regulation—critical for dissecting acid-base homeostasis and disease mechanisms.

450 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page